Los Angeles Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.1M Buy
233,748
+226,889
+3,308% +$20.4M 0.08% 186
2025
Q4
$416K Sell
6,859
-120
-2% -$9.11K ﹤0.01% 967
2025
Q3
$400K Buy
6,979
+2,627
+60% +$151K ﹤0.01% 1012
2025
Q2
$257K Sell
4,352
-897
-17% -$58K ﹤0.01% 1105
2025
Q1
$384K Buy
5,249
+540
+11% +$44.6K ﹤0.01% 819
2024
Q4
$389K Hold
4,709
﹤0.01% 874
2024
Q3
$337K Hold
4,709
﹤0.01% 974
2024
Q2
$323K Hold
4,709
﹤0.01% 987
2024
Q1
$253K Sell
4,709
-117,089
-96% -$6.29M ﹤0.01% 1058
2023
Q4
$6.49M Sell
121,798
-466,202
-79% -$22.7M 0.02% 305
2023
Q3
$29.2M Sell
588,000
-211,021
-26% -$11.8M 0.12% 156
2023
Q2
$47.6M Buy
799,021
+743,129
+1,330% +$42.4M 0.19% 111
2023
Q1
$3.17M Buy
55,892
+50,412
+920% +$3.23M 0.01% 411
2022
Q4
$407K Sell
5,480
-37,902
-87% -$2.58M ﹤0.01% 947
2022
Q3
$2.58M Sell
43,382
-2,100
-5% -$126K 0.01% 458
2022
Q2
$2.55M Buy
45,482
+5,840
+15% +$384K 0.01% 479
2022
Q1
$2.92M Hold
39,642
0.01% 453
2021
Q4
$2.86M Buy
39,642
+14,182
+56% +$1.03M 0.01% 436
2021
Q3
$1.95M Hold
25,460
0.01% 534
2021
Q2
$1.97M Hold
25,460
0.01% 592
2021
Q1
$1.57M Sell
25,460
-145
-0.6% -$9.18K 0.01% 699
2020
Q4
$1.67M Sell
25,605
-435
-2% -$25K 0.01% 726
2020
Q3
$1.29M Buy
26,040
+694
+3% +$35.8K 0.01% 721
2020
Q2
$1.21M Sell
25,346
-21,592
-46% -$1.04M 0.01% 782
2020
Q1
$2M Sell
46,938
-7,900
-14% -$390K 0.01% 535
2019
Q4
$3.23M Sell
54,838
-13,884
-20% -$754K 0.02% 522
2019
Q3
$3.51M Sell
68,722
-15,140
-18% -$721K 0.02% 486
2019
Q2
$3.55M Sell
83,862
-1,490
-2% -$64.7K 0.02% 516
2019
Q1
$4.22M Buy
85,352
+6,730
+9% +$304K 0.02% 466
2018
Q4
$3.4M Buy
78,622
+18,195
+30% +$908K 0.02% 433
2018
Q3
$3.43M Buy
60,427
+53,465
+768% +$2.81M 0.02% 529
2018
Q2
$351K Hold
6,962
﹤0.01% 1242
2018
Q1
$347K Hold
6,962
﹤0.01% 1143
2017
Q4
$286K Sell
6,962
-13,524
-66% -$473K ﹤0.01% 1188
2017
Q3
$609K Buy
20,486
+7,780
+61% +$238K ﹤0.01% 968
2017
Q2
$421K Sell
12,706
-1,510
-11% -$47.4K ﹤0.01% 981
2017
Q1
$421K Buy
+14,216
New +$388K ﹤0.01% 922

Other funds holding GMED